Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.30−0.10 (-1.19%)
Close on Nov 19, 2026Market cap $87.57MP/E –Yield –
Biodesix price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Biodesix's price to sales ratio was 1.0× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.7× to 93.4×, with a median of 38.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | +0.4 |
| 2025 | Dec 31, 2025 | 0.7× | −67.2 |
| 2024 | Dec 31, 2024 | 67.9× | −5.9 |
| 2023 | Dec 29, 2023 | 73.8× | +20.9 |
| 2022 | Dec 30, 2022 | 52.9× | +14.4 |
| 2021 | Dec 31, 2021 | 38.5× | +34.1 |
| 2020 | Dec 31, 2020 | 4.4× | – |
See a number that looks wrong?